Drugs / MR4
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00719745 | Feb 2006 → Jun 2008 | hepatic infarction | Astellas Pharma Inc | Completed | No outcome recorded |
| Phase 3 | NCT00720265 | Feb 2006 → Mar 2008 | — | Astellas Pharma Inc | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MR4 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00720265 ↗ |